WO2010121919A1 - Hair care composition comprising trichogen complex and an azole - Google Patents

Hair care composition comprising trichogen complex and an azole Download PDF

Info

Publication number
WO2010121919A1
WO2010121919A1 PCT/EP2010/054802 EP2010054802W WO2010121919A1 WO 2010121919 A1 WO2010121919 A1 WO 2010121919A1 EP 2010054802 W EP2010054802 W EP 2010054802W WO 2010121919 A1 WO2010121919 A1 WO 2010121919A1
Authority
WO
WIPO (PCT)
Prior art keywords
hair treatment
treatment composition
composition according
mixtures
extract
Prior art date
Application number
PCT/EP2010/054802
Other languages
French (fr)
Inventor
Jason Shaun Burry
Richard Livesey Evans
Graham Andrew Turner
Original Assignee
Unilever Plc
Unilever N.V.
Hindustan Unilever Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc, Unilever N.V., Hindustan Unilever Limited filed Critical Unilever Plc
Publication of WO2010121919A1 publication Critical patent/WO2010121919A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners

Definitions

  • the present invention relates to hair care compositions in particular compositions that maximize hair growth.
  • Hair growth is of commercial interest to many groups of consumer.
  • Male baldness or hair thinning is a problem for one market segment, a second market segment is people who are not bald but require their hair to appear thick and voluminous.
  • the predominant products are pharmaceuticals, although not all the products that are marketed in this segment are drug products.
  • the prior art includes many patents disclosing hair grooming compositions which illustrate the state of the art in herbal based compositions for promoting hair health and growth.
  • U.S. Pat. No. 604,111 discloses a hair tonic of mountain sage, glycerin, tincture of lobelia, prickly pear juice, tincture of capsicum, sweet oil, and alcohol, which cleans the scalp, relaxes and stimulates the scalp, cools the scalp and gives the hair gloss.
  • US 2007/0036742 discloses a composition for preventing or decreasing hair loss comprising a mixture of plant extracts such as green tea.
  • US 6 232 302 discloses compositions comprising depolymehses fucane sulphates for increasing hair growth.
  • compositions comprising cysteine, lysine, and a glycoprotein are disclosed in EP 1 089 704 for trichological use. Despite the prior art there remains the need for improved compositions for reducing hair loss.
  • the present invention relates to a hair treatment composition
  • a hair treatment composition comprising a trichogenic material and from 0.0002 to 0.0049 of an additional anti-dandruff agent.
  • the composition of the invention comprises a trichogenic material.
  • the trichogenic material comprises a synergistic trichogenic mixture of the following: a protein biosynthesis stimulant preferably selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts, particularly preferred are sulfopeptides of soy and amino acids, especially tyrosine, arginine, ornithine and citrulline.
  • the synergistic trichogenic mixture may comprise a glycosamino production agent is selected from the group consisting of glucosamine, L-fucose; fucose rich polysaccharide, xylose,vitamin C, Eriobotrya japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof. Particularly preferred is glucosamine.
  • the synergistic trichogenic mixture may comprise a cell nutrition regulator especially vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof. Particularly preferred are vitamins of the B group, especially PP, B5 and biotin.
  • the synergistic trichogenic mixture may comprise a microcirculation promoter, preferred promoters are Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, ⁇ -lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof. Particularly preferred are Panax Ginseng Extract, Arctium Majus Extract.
  • the trichogenic material comprises a synergistic mixture of a healthy scalp protein biosynthesis stimulant, a glycosamino production agent, a cell nutrition regulator, a microcirculation promotor and mixtures thereof.
  • the protein biosynthesis stimulant is selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts.
  • the glycosamino production agent is selected from glucosamine, L- fucose; fucose rich polysaccharide xylose,vitamin C, Eriobotrya Japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof.
  • the cell nutrition regulator is selected from vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof.
  • the microcirculation promoter is selected from Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, a-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof.
  • Thchogen® ex Cognis in particular Trichogen® Veg LS 8960.
  • the level of the synergistic trichogenic mixture is preferably from 0.001 to 20 wt% of the total composition, more preferably from 0.1 to 15 wt% of the total composition, most preferably from 0.2 1 10 wt% of the total composition.
  • the antidandruff agent is selected from the group consisting of zinc pyrithione, octopirox, climbazole, ketoconazole and mixtures thereof.
  • Azole based antidandruff agents are the most preferred, in particular climbazole.
  • the anti-dandruff agent is therefore preferably soluble in the composition of the invention at 25°C.
  • the level of anti-dandruff agent is preferably from 0.0002 to 0.0049 wt%, more preferably from 0.0007 to 0.003 wt% of the total composition.
  • composition of the invention further comprises an ant- inflammatory agent.
  • the anti-inflammatory agent is selected from the group consisting of hyssop extract, turmeric extract, arnica extract, willow bark extract, sesquiterpene extract, salicylic acid and mixtures thereof.
  • An especially preferred anti-inflammatory agent is salicylic acid.
  • the final product form of hair treatment compositions according to the invention may suitably be, for example, shampoos, conditioners, sprays, mousses, gels, oils, creams, waxes or lotions.
  • Particularly preferred product forms are leave-on products (those products that are not immediately rinsed off after application and are preferably left on for at least one hour, more preferably for at least 5 hours).
  • Post-wash conditioners are preferred (especially leave-in) as are hair treatment products such as hair essences.
  • composition according to the invention is preferably a conditioning composition and will comprise a conditioning active.
  • conditioning actives include fatty alcohols, cationic surfactants and silicones.
  • the amount of product applied will vary according to the form of the product, but will normally be in accordance with the industry accepted methodology for the use of a product of the same type.
  • a representative application procedure will involve application of the formulation to the area in need of treatment once or twice a day, and leaving the formulation in place for a period of several hours.
  • the following experiment uses trypsin as a model for the serine proteases involved in the process of hair fall. Successful inhibition the activity of the serine proteases such as trypsin is thought to delay the onset of hair fall.
  • the EnzChek Protease Assay (E6639, Molecular Probes) was used to measure trypsin activity.
  • Lexamine S13 Ex Inolex Chemical Company is Stearamidopropyl Dimethylamine.
  • Ganamin BTLF (ex Clariant) is Behenthmonium Chloride Laurex CS (ex Albright and Wilson) is Cetearyl Alcohol. Leave-on serum
  • Carbopol Ultrez 20 (ex Noveon) is a hydrophobically modified cross-linked acrylate copolymer (Acrylates/C 10-30 Alkyl Acrylate Crosspolymer).
  • Rhodasurf L790 is polyoxyethylene 7 lauryl alcohol (Laureth-7).
  • Eumulgin L (ex Cognis) is PPG-1 -PEG-9 Lauryl Glycol Ether.

Abstract

A hair treatment composition comprising a trichogenic material and from 0.0002 to 0.0049% wt. of an additional anti-dandruff agent.

Description

HAIR CARE COMPOSITION COMPRISING TRICHOGEN COMPLEX AND AN AZOLE
The present invention relates to hair care compositions in particular compositions that maximize hair growth.
Hair growth is of commercial interest to many groups of consumer. Male baldness or hair thinning is a problem for one market segment, a second market segment is people who are not bald but require their hair to appear thick and voluminous. For male baldness the predominant products are pharmaceuticals, although not all the products that are marketed in this segment are drug products.
The prior art includes many patents disclosing hair grooming compositions which illustrate the state of the art in herbal based compositions for promoting hair health and growth.
U.S. Pat. No. 604,111 discloses a hair tonic of mountain sage, glycerin, tincture of lobelia, prickly pear juice, tincture of capsicum, sweet oil, and alcohol, which cleans the scalp, relaxes and stimulates the scalp, cools the scalp and gives the hair gloss.
US 2007/0036742 discloses a composition for preventing or decreasing hair loss comprising a mixture of plant extracts such as green tea.
US 6 232 302 discloses compositions comprising depolymehses fucane sulphates for increasing hair growth.
Compositions comprising cysteine, lysine, and a glycoprotein are disclosed in EP 1 089 704 for trichological use. Despite the prior art there remains the need for improved compositions for reducing hair loss.
The present invention relates to a hair treatment composition comprising a trichogenic material and from 0.0002 to 0.0049 of an additional anti-dandruff agent.
The composition of the invention comprises a trichogenic material. Preferably the trichogenic material comprises a synergistic trichogenic mixture of the following: a protein biosynthesis stimulant preferably selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts, particularly preferred are sulfopeptides of soy and amino acids, especially tyrosine, arginine, ornithine and citrulline.
The synergistic trichogenic mixture may comprise a glycosamino production agent is selected from the group consisting of glucosamine, L-fucose; fucose rich polysaccharide, xylose,vitamin C, Eriobotrya japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof. Particularly preferred is glucosamine.
The synergistic trichogenic mixture may comprise a cell nutrition regulator especially vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof. Particularly preferred are vitamins of the B group, especially PP, B5 and biotin.
The synergistic trichogenic mixture may comprise a microcirculation promoter, preferred promoters are Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, α-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof. Particularly preferred are Panax Ginseng Extract, Arctium Majus Extract.
Preferably, the trichogenic material comprises a synergistic mixture of a healthy scalp protein biosynthesis stimulant, a glycosamino production agent, a cell nutrition regulator, a microcirculation promotor and mixtures thereof.
Preferably, the protein biosynthesis stimulant is selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts.
Preferably, the glycosamino production agent is selected from glucosamine, L- fucose; fucose rich polysaccharide xylose,vitamin C, Eriobotrya Japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof.
Preferably, the cell nutrition regulator is selected from vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof.
Preferably, the microcirculation promoter is selected from Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, a-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof.
A particularly preferred synergistic trichogenic mixture is known as Thchogen® ex Cognis, in particular Trichogen® Veg LS 8960.
The level of the synergistic trichogenic mixture is preferably from 0.001 to 20 wt% of the total composition, more preferably from 0.1 to 15 wt% of the total composition, most preferably from 0.2 1 10 wt% of the total composition. - A -
The antidandruff agent is selected from the group consisting of zinc pyrithione, octopirox, climbazole, ketoconazole and mixtures thereof. Azole based antidandruff agents are the most preferred, in particular climbazole.
The anti-dandruff agent is therefore preferably soluble in the composition of the invention at 25°C.
The level of anti-dandruff agent is preferably from 0.0002 to 0.0049 wt%, more preferably from 0.0007 to 0.003 wt% of the total composition.
It is preferable if the composition of the invention further comprises an ant- inflammatory agent. Preferably the anti-inflammatory agent is selected from the group consisting of hyssop extract, turmeric extract, arnica extract, willow bark extract, sesquiterpene extract, salicylic acid and mixtures thereof. An especially preferred anti-inflammatory agent is salicylic acid.
The final product form of hair treatment compositions according to the invention may suitably be, for example, shampoos, conditioners, sprays, mousses, gels, oils, creams, waxes or lotions. Particularly preferred product forms are leave-on products (those products that are not immediately rinsed off after application and are preferably left on for at least one hour, more preferably for at least 5 hours). Post-wash conditioners are preferred (especially leave-in) as are hair treatment products such as hair essences.
Accordingly, the composition according to the invention is preferably a conditioning composition and will comprise a conditioning active. Preferred conditioning actives include fatty alcohols, cationic surfactants and silicones.
The amount of product applied will vary according to the form of the product, but will normally be in accordance with the industry accepted methodology for the use of a product of the same type. A representative application procedure will involve application of the formulation to the area in need of treatment once or twice a day, and leaving the formulation in place for a period of several hours.
The invention is further illustrated by the following non-limiting examples:
Examples
The following experiment uses trypsin as a model for the serine proteases involved in the process of hair fall. Successful inhibition the activity of the serine proteases such as trypsin is thought to delay the onset of hair fall.
The EnzChek Protease Assay (E6639, Molecular Probes) was used to measure trypsin activity.
Example 1
1.5% Trichogen plus 0.00391 % climbazole
Figure imgf000006_0001
Data generated from an enzyme assay. Calculated efficacy is the mean activity of (Climbazole + Trichogen)/2
Experimental activity is the measure activity with the two ingredients present.
EXAMPLE 2
The following are formulations comprising climbazole and trichogen. Shampoo
Figure imgf000007_0001
Conditioner
Figure imgf000007_0002
Lexamine S13 (ex Inolex Chemical Company is Stearamidopropyl Dimethylamine.
Ganamin BTLF (ex Clariant) is Behenthmonium Chloride Laurex CS (ex Albright and Wilson) is Cetearyl Alcohol. Leave-on serum
Figure imgf000008_0001
Carbopol Ultrez 20 (ex Noveon) is a hydrophobically modified cross-linked acrylate copolymer (Acrylates/C 10-30 Alkyl Acrylate Crosspolymer).
Rhodasurf L790 (ex Rhodia) is polyoxyethylene 7 lauryl alcohol (Laureth-7).
Eumulgin L (ex Cognis) is PPG-1 -PEG-9 Lauryl Glycol Ether.

Claims

Claims
1. A hair treatment composition comprising a thchogenic material and from 0.0002 to 0.0049% wt. of an additional anti-dandruff agent.
2. A hair treatment composition according to claim 1 in which the thchogenic material comprises a synergistic mixture of a healthy scalp protein biosynthesis stimulant, a glycosamino production agent, a cell nutrition regulator, a microcirculation promoter and mixtures thereof.
3. A hair treatment composition according to claim 2 in which the protein biosynthesis stimulant is selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts.
4. A hair treatment composition according to claim 2 or claim 3 in which the glycosamino production agent is selected from glucosamine, L-fucose; fucose rich polysaccharide xylose,vitamin C, Eriobotrya Japonica extract, N- acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof.
5. A hair treatment composition according to any one of claims 2 to 4 in which the cell nutrition regulator is selected from vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof.
6. A hair treatment composition according to any one of claims 2 to 5 in which the microcirculation promoter is selected from Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, a-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof.
7. A hair treatment composition according to any preceding claim in which the level of the trichogenic material is from 0.1 to 20 wt% of the total composition.
8. A hair treatment composition according to any preceding claim in which the anti-dandruff agent is selected from the group consisting of zinc pyrithione, octopirox, climbazole, ketoconazole or mixtures thereof.
9. A hair treatment composition according to claim 7 in which the anti-dandruff agent is an azole.
10. A hair treatment composition according to claim 9 in which the anti-dandruff agent is climbazole.
PCT/EP2010/054802 2009-04-23 2010-04-13 Hair care composition comprising trichogen complex and an azole WO2010121919A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09158656.0 2009-04-23
EP09158656 2009-04-23

Publications (1)

Publication Number Publication Date
WO2010121919A1 true WO2010121919A1 (en) 2010-10-28

Family

ID=41066034

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/054802 WO2010121919A1 (en) 2009-04-23 2010-04-13 Hair care composition comprising trichogen complex and an azole

Country Status (1)

Country Link
WO (1) WO2010121919A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013083645A2 (en) 2011-12-07 2013-06-13 Unilever Plc Skin lightening composition
CN104168883A (en) * 2013-09-12 2014-11-26 拉芳家化股份有限公司 Shampoo composition including efficient anti-remval agent
WO2018064468A1 (en) * 2016-09-30 2018-04-05 The Regents Of The University Of California Alpha-ketobutyrate, alpha-ketoglutarate, and 2-hydroxybutyrate for stimulating hair growth
US11800917B2 (en) * 2018-08-30 2023-10-31 L'oreal Hair-treatment compositions and methods of use

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US604111A (en) 1898-05-17 Hair-tonic
EP0489581A2 (en) * 1990-12-04 1992-06-10 Unilever Plc Cosmetic composition
EP0674897A2 (en) * 1994-03-31 1995-10-04 Shiseido Company Limited Hair composition
EP1089704A1 (en) 1998-06-22 2001-04-11 Gecomwert Anstalt Trichological lotion for topical use
US6232302B1 (en) 1998-06-16 2001-05-15 Crinos Industria Farmacobiologica S.P.A. Agents and compositions thereof for the hair treatment
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
WO2002007700A2 (en) * 2000-07-26 2002-01-31 The Procter & Gamble Company Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
US20070036742A1 (en) 2005-08-09 2007-02-15 Access Business Group International Llc Methods and compositions for modulating hair growth or regrowth

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US604111A (en) 1898-05-17 Hair-tonic
EP0489581A2 (en) * 1990-12-04 1992-06-10 Unilever Plc Cosmetic composition
EP0674897A2 (en) * 1994-03-31 1995-10-04 Shiseido Company Limited Hair composition
US6232302B1 (en) 1998-06-16 2001-05-15 Crinos Industria Farmacobiologica S.P.A. Agents and compositions thereof for the hair treatment
EP1089704A1 (en) 1998-06-22 2001-04-11 Gecomwert Anstalt Trichological lotion for topical use
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
WO2002007700A2 (en) * 2000-07-26 2002-01-31 The Procter & Gamble Company Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
US20070036742A1 (en) 2005-08-09 2007-02-15 Access Business Group International Llc Methods and compositions for modulating hair growth or regrowth

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TIM FABER: "Trichogen Complex-Stop Hair Loss and PRomote Hair Growth", EZINE @RTICLES, 3 June 2008 (2008-06-03), XP002546966, Retrieved from the Internet <URL:http://ezinearticles.com/?Trichogen-Complex---Stop-Hair-Loss-and-Promote-Hair-Growth&id=1222597> *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013083645A2 (en) 2011-12-07 2013-06-13 Unilever Plc Skin lightening composition
CN104168883A (en) * 2013-09-12 2014-11-26 拉芳家化股份有限公司 Shampoo composition including efficient anti-remval agent
WO2015035585A1 (en) * 2013-09-12 2015-03-19 拉芳家化股份有限公司 Shampoo composition containing complexing agent for efficiently preventing hair loss
CN104168883B (en) * 2013-09-12 2016-05-25 拉芳家化股份有限公司 A kind of shampoo composite containing efficient anticreep complexing agent
WO2018064468A1 (en) * 2016-09-30 2018-04-05 The Regents Of The University Of California Alpha-ketobutyrate, alpha-ketoglutarate, and 2-hydroxybutyrate for stimulating hair growth
US11800917B2 (en) * 2018-08-30 2023-10-31 L'oreal Hair-treatment compositions and methods of use

Similar Documents

Publication Publication Date Title
EP2200577B1 (en) Hair care composition
EP1755547B1 (en) Haircare compositions and methods
JP5351358B2 (en) Hair care composition for improving hair appearance
US20040241114A1 (en) Hair Care and Nail Care Compositions Based on Ion-Pair Delivery System for Gender and Ethnic Selective Applications
JP2006282597A (en) Hair papilla cell growth promoter, vascular endothelial growth factor (vegf) production promoter and hair-restoring or growing agent
US8985124B2 (en) Method for treatment of hair loss with a combination of natural ingredients
KR20140107784A (en) Composition for preventing falling out of the hair and promoting growth of the hair
WO2010121919A1 (en) Hair care composition comprising trichogen complex and an azole
KR20110045341A (en) Improvement composite of scalp and hair be contain yeast, gold, propolis, ginseng, purslane, clove, pleuropterus multiflorus
KR100801164B1 (en) The compound for trichogenousness and preventing the depilation and cosmetic composition thereof
AU673742B2 (en) Composition for reducing hair loss or stimulating hair growth
KR20120051199A (en) Cosmetic compositions for hair or scalp to prevent hair loss and promote growing hair
RU2170570C1 (en) Composition for hair washing
Pavithra et al. A comparative study of topical procapil with platelet-rich plasma therapy versus topical redensyl, saw palmetto, and biotin with platelet-rich plasma therapy in the treatment of androgenetic alopecia
US10543227B2 (en) Hair growth composition
CN113633585A (en) External hair care composition and preparation with effects of preventing alopecia, growing hair and blackening hair and preparation method thereof
US8759385B2 (en) Composition comprising azole fungicide and water soluble metal salt
CN111110618B (en) A composition for promoting hair growth
KR20090070089A (en) Composition for prevention of hair loss and stimulation of hair growh
US20050180940A1 (en) Protect against hair loss
EP3785697A1 (en) Cosmetic compositions comprising piperlongumine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10713459

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10713459

Country of ref document: EP

Kind code of ref document: A1